Maternal and fetal effects of acromegaly on pregnancy. Clinical Practice and Drug Treatment

被引:0
|
作者
Arefzadeh, Alireza [1 ]
Shalbaf, Nazanin Azizi [1 ]
Khalighinejad, Pooyan [2 ]
Darvishzadeh, Amirhossein [1 ]
机构
[1] Zanjan Univ Med Sci, Vali Asr Hosp, Zanjan Metab Dis Res Ctr, Zanjan, Iran
[2] Isfahan Univ Med Sci, Sch Med, Esfahan, Iran
关键词
Acromegaly; pregnancy; pituitary tumor; pituitary adenoma; Growth Hormone excess;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
INTRODUCTION: Pregnancy in acromegaly is usually rare. Acromegaly is related with secondary hypogonadism, hyperandrogenemia, hyper prolactin and pregnancy is difficult in acromegaly, however, some women with acromegaly may be become pregnant, which brings along questions about maternal and fetal effects and medical therapy and treatment. This review helps to address these points and helps clinical information. METHODS: This review summarizes maternal and fetal effects of acromegaly on pregnancy and medical treatment RESULTS AND CONCLUSION: Acromegaly can effect on pregnancy. In summary, fertility is usually compromised in acromegaly due to hyperandrogenemia, impairment of gonadotropin-secreting cells and decreased secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH) as a result of tumoral mass effect (pituitary stalk compression) or treatment (surgery and radiotherapy) or hypopituitarism, high prolactin hormone levels due to pituitary stalk compression and a mixed GH-prolactin secreting adenoma and direct effect of excess GH/IGF-I on the gonadotropic axis.[1-6] Pregnancy may become complicated with gravid hypertension, preeclampsia and gestational diabetes mellitus. [7] Dopaminergic drugs, octreotide, pegvisomant and surgery are different modalities for treatment acromegaly in pregnancy. [8-13]
引用
收藏
页码:952 / 960
页数:9
相关论文
共 50 条
  • [1] Treatment of acromegaly with pegvisomant during pregnancy: Maternal and fetal effects
    Brian, Susan Riddle
    Bidlingmaier, Martin
    Wajnrajch, Michael P.
    Weinzimer, Stuart A.
    Inzucchi, Silvio E.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (09): : 3374 - 3377
  • [2] Fetal and maternal lipoproteins in normal and diabetic pregnancy.
    Kilby, M
    Neary, RH
    Whittle, M
    [J]. ATHEROSCLEROSIS, 1997, 128 (02) : 24 - 24
  • [3] Fetal DNA in the maternal plasma, in early pregnancy. Its use as a marker of abnormal pregnancy.
    Crowley, A
    Sheils, O
    Martin, C
    Fitzpatrick, P
    O'Herlihy, C
    O'Leary, J
    Byrne, B
    [J]. JOURNAL OF PATHOLOGY, 2004, 204 : 42A - 42A
  • [4] Intrahepatic cholestasis of pregnancy. Maternal and fetal implications.
    Gonzalez, A
    Mino, M
    Fontes, J
    Suarez, JF
    Pinel, LM
    Espinosa, MD
    Miranda, JA
    MartinVivaldi, R
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1996, 88 (11) : 780 - 784
  • [5] Unique fetal and maternal virilization due to luteoma of pregnancy.
    Gandhi, RK
    Talati, A
    Danish, RK
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S261 - S261
  • [6] Malformations in neural crest derived fetal organs and effects of maternal vitamin E treatment in diabetic rat pregnancy.
    Eriksson, UJ
    Simán, CM
    Wisse, B
    Gittenberger-de Groot, AC
    [J]. DIABETOLOGIA, 1999, 42 : A22 - A22
  • [7] Maternal and fetal outcomes of conscious sedation and endoscopy during pregnancy.
    Colon, VJ
    Ramirez, FC
    Cappell, MS
    [J]. GASTROINTESTINAL ENDOSCOPY, 1997, 45 (04) : 91 - 91
  • [8] The aftermath from fetal-maternal cell traffic of pregnancy.
    Nelson, JL
    [J]. BIOLOGY OF REPRODUCTION, 2005, : 68 - 68
  • [9] Presence of fetal DNA in maternal plasma decades after pregnancy.
    Invernizzi, P
    Biondi, ML
    Simoni, G
    Podda, M
    [J]. BLOOD, 2001, 98 (11) : 35B - 35B
  • [10] Maternal Hepcidin Determines Fetal Iron Homeostasis during Pregnancy.
    Sangkhae, Veena
    Fisher, Allison L.
    Ganz, Tomas
    Nemeth, Elizabeta
    [J]. REPRODUCTIVE SCIENCES, 2018, 25 : 224A - 224A